HFA Premium Access

Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction: findings from the CHAMP-HF registry

Congress Session

About the speaker

Doctor Yevgeniy Khariton

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
1 presentation
0 follower

11 more presentations in this session

Discussion - Sacubitril/Valsartan initiation and health status outcomes in HFrEF

Thumbnail

Subtle ventricular dysfunction outperforms other risk markers in patients with coronary artery disease

Speaker: Professor D. Kotecha (Birmingham, GB)

Thumbnail

Discussion - ARM-CAD

Thumbnail

Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

Speaker: Professor K. Branch (Seattle, US)

Thumbnail

Discussion - COMPASS CHF

Thumbnail

Access the full session

Late breaking trial IV - Registries

Speakers: Doctor Y. Khariton, Professor D. Kotecha, Professor K. Branch
Thumbnail

About the event

Image

Heart Failure 2018 & World Congress on Acute Heart Failure

26 May - 29 May 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk